NCT00509288 |
|
Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Infusion of Anti-MART-1 F5 TCR-Gene-Engineered Lymphocytes
|
View
|
NCT00706992 |
|
Anti-MART-1 F5 Lymphocytes to Treat High-Risk Melanoma Patients
|
View
|
NCT00910650 |
|
Study of Gene Modified Immune Cells in Patients With Advanced Melanoma
|
View
|
NCT01035190 |
|
Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia
|
View
|
NCT00612222 |
|
Anti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced Melanoma
|
View
|
NCT03969498 |
|
Evaluation of the Incidence of Cancer in the Follow-up of Women With 3 Consecutive Embryonic Demises Before 10 Weeks or 1 Fetal Death According to Their Thrombophilia Status With a Special Focus on Women With an Obstetric Antiphospholipid Symdrome oAPS
|
View
|
NCT05233384 |
|
Genomics of Fibrin Clot Structure in Patients With Constitutional Dysfibrinogenemia
|
View
|
NCT01829126 |
|
Development and Prevention of Severe Heart Disease in Systemic Sclerosis
|
View
|
NCT01834157 |
|
Improvement of Hand Dysfunction by Arthritis in Systemic Sclerosis
|
View
|
NCT01836263 |
|
Prevention and Treatment of Digital Ulcers in Systemic Sclerosis
|
View
|
NCT01840748 |
|
Development and Prevention of Pulmonary Hypertension in Systemic Sclerosis
|
View
|
NCT01858259 |
|
Treatment and Prevention of Progression of Interstitial Lung Disease in Systemic Sclerosis
|
View
|